ORMELOXIFENE: REVOLUTIONIZING THE MANAGEMENT OF DYSFUNCTIONAL UTERINE BLEEDING
Keywords:
Ormeloxifene, Dysfunctional Uterine Bleeding, Selective Estrogen Receptor ModulatorAbstract
Article explores the efficacy and safety of ormeloxifene, a selective estrogen receptor modulator, in the treatment of dysfunctional uterine bleeding (DUB). Dysfunctional uterine bleeding is a common gynecological disorder characterized by irregular menstrual bleeding due to hormonal imbalances. This review examines the pharmacological properties of ormeloxifene, its mechanisms of action in regulating menstrual cycles, and its clinical outcomes in the management of DUB. The potential benefits, side effects, and future directions for research are also discussed, highlighting ormeloxifene as a promising therapeutic option for DUB.
Downloads
References
Fraser IS, Critchley HO, Broder M. Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. In: Seminars in reproductive medicine: Thieme Medical Publishers; 2011; 29:383-390.
Paula J. Adams Hillard. Benign disease of Female Reproductive tract. In: Berek JS (Editor). Berek and Novak’s Gynecology. Philadelphia: Lippincott Williams and Wilkins; 591-609.
Padubidri VG, Daftary SN. Howkins and Bourne. Shaw’s Textbook of Gynaecology. 16thed: Elseiver, 2015; 335-348.
Speroff L, Fritz MA, Clinical Gynecologic Endocrinology And Infertility, Eighth ed. p-591-609.
Tandon AM, Goel I. The effect of ormeloxifene, a selective estrogen receptor modulator, on the biomarkers of the endometrial receptivity and the pinopode development and its relationship with the fertility and the infertility in Indian subjects: Fertility and Sterility. 2009; 91: 2298-307.
Lal J. Clinical pharmacokinetics and interaction of centchroman-a mini review. Contraception. 2010; 81: 275–80.
Higham JM, O’ Brein PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990; 97:734-9.
Biswas SC, Saha SK, Bag TS, Ghosh Roy SC, Roy AC, Kabiraj SP. Ormeloxifene, A Selective Estrogen Receptor Modulator, for treatment of dysfunctional menorrhagia. J Obstet Gynecol. 2004; 54:56-9.
Kriplani A, Kulshrestha B, Agarwal N. Effeciency and safety of ormeloxifene in management of menorrhagia:a pilot study. J Obstet Gynecol Res. 2009; 35:746-52.
Bhattacharyya TK, Banerji A. Efficacy of a selective estrogen receptor modulator: ‘ormeloxifene’ in management of dysfunctional uterine bleeding. South Asian Federat Obstet Gynaecol. 2010; 2:207-11.
